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Abstract
Background: Over the last decade, the number of neurostimulator systems
implanted in patients has been rapidly growing. Nearly 50, 000 neurostimulators are
implanted worldwide annually. The most common type of implantable
neurostimulators is indicated for pain relief. At the same time, commercial use of
other electromagnetic technologies is expanding, making electromagnetic
interference (EMI) of neurostimulator function an issue of concern. Typically reported
sources of neurostimulator EMI include security systems, metal detectors and wireless
equipment. When near such sources, patients with implanted neurostimulators have
reported adverse events such as shock, pain, and increased stimulation. In recent in
vitro studies, radio frequency identification (RFID) technology has been shown to
inhibit the stimulation pulse of an implantable neurostimulator system during low
frequency exposure at close distances. This could potentially be due to induced
electrical currents inside the implantable neurostimulator leads that are caused by
magnetic field coupling from the low frequency identification system.
Methods: To systematically address the concerns posed by EMI, we developed a test
platform to assess the interference from coupled magnetic fields on implantable
neurostimulator systems. To measure interference, we recorded the output of one
implantable neurostimulator, programmed for best therapy threshold settings, when
in close proximity to an operating low frequency RFID emitter. The output contained
electrical potentials from the neurostimulator system and those induced by EMI from
the RFID emitter. We also recorded the output of the same neurostimulator system
programmed for best therapy threshold settings without RFID interference. Using the
Spatially Extended Nonlinear Node (SENN) model, we compared threshold factors of
spinal cord fiber excitation for both recorded outputs.
Results: The electric current induced by low frequency RFID emitter was not
significant to have a noticeable effect on electrical stimulation.
Conclusions: We demonstrated a method for analyzing effects of coupled magnetic
field interference on implantable neurostimulator system and its electrodes which
could be used by device manufacturers during the design and testing phases of the
development process.
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Radio frequency identification (RFID) readers are being used for tracking people, ani-
mals, products and goods. Some of the advantages of this technology include proximity
of identification and robust ability to store information. RFID readers can identify tags
within meters away. This technology works by emitting and receiving radio frequency
electromagnetic energy. Since RFID technology has gained popularity in many indus-
tries, an average person could get exposed to the emitted fields from RFID readers
when using public transportation, shopping at a grocery store, picking up a package at
a postal service and driving through a toll booth [1,2].
The United States Food and Drug Administration (FDA) is encouraging use of a
state-of-the-art technology, such as RFID, to allow manufacturers and distributors to
precisely track drug products through the supply chain [3]. Overall, RFID systems offer
a variety of benefits, including fast transactions, real time tracking, contactless data
transfer, large storage capacity and continuous temperature monitoring. Some claim
that RFID technology can change the delivery of patient care [4].
In recent years, the FDA has received a series of adverse event reports suggesting
electromagnetic interference (EMI) with deep brain and spinal cord stimulators from
various electromagnetic sources [5]. Kainz et. al. reported various sources of EMI,
which included a report from a patient with an implantable spinal cord stimulator who
received an electric shock while walking near an article surveillance device [6]. Several
incident reports and published literature culminated in the 1998 FDA advisory to car-
diologists, cardiovascular surgeons, emergency physicians, neurologists and neurosur-
geons warning that the operation of certain medical devices, including spinal cord
stimulators, may be affected by the electromagnetic fields produced by anti-theft sys-
tems and metal detectors [7].
In our recent study, we investigated the EMC of six implantable neurostimulators
and 22 RFID emitters. We found effects of inhibition of one implantable neurostimula-
tor system indicated for incontinence when close to two low frequency RFID emitters.
The effects were determined to be clinically significant only if they occurred for
extended periods of time. There were no observed effects on the other 5 implantable
neurostimulators or during exposures from other RFID emitters [8]. Another publica-
tion reported that magnetic fields can turn the stimulation on or off and varying mag-
netic fields can momentarily inhibit telemetry [9].
A previously published study has shown that magnetic resonance systems are capable
of generating strong magnetic fields that could potentially cause nerve stimulation. The
induced fields inside the patients with implantable leads are much larger than induced
fields inside patients with no implantable systems [10]. To address the concerns posed
by coupling of electromagnetic fields from RFID emitters, we developed a test protocol
to assess the interference from coupled magnetic fields on implantable neurostimulator
systems.
Background Theory
In the 1830s, Michael Faraday proposed a hypothesis that a magnetic field could pro-
duce an electric current in a wire. After 10 years of experiments, Michael Faraday and
Joseph Henry independently discovered that magnetic fields can produce an electric
current in a closed loop, but only if magnetic flux linking the surface area of the loop
Pantchenko et al. BioMedical Engineering OnLine 2011, 10:94
http://www.biomedical-engineering-online.com/content/10/1/94
Page 2 of 11changes with time. This type of process was named electromagnetic induction. The
electric current can be generated under any one of the three conditions:
1. A stationary loop in a time varying magnetic field,
2. A moving loop with a time varying area in a static magnetic field, or
3. A moving loop in a time varying magnetic field [11].
One hundred and eighty years later, the same theory still holds. This relation is now
known as Faraday’s law of induction.
In our work, we chose to focus on the first example of a stationary loop in a time
varying magnetic field since it represents the worst case scenario of magnetic fields
coupling at the minimum separation distance. In our study, the time varying magnetic
field is generated by the RFID emitter and a stationary loop is formed by the implanta-
ble neurostimulator leads.
In the case of a single turn, conducting circular loop with surface area A in a time
varying magnetic field B(t), the electrical potential difference between the ends of leads
is defined as,
V=

∂/∂tB · dA
where,
V: electrical potential difference (V)
∂/∂t B: rate of change of the magnetic field (T/s)
A: surface area of the enclosed loop (m
2) [11]
Methods
Probe for measuring electrical potential difference
We designed a probe for measuring the electrical potential difference between two
contacts of the pulse generator. The probe was made of solid conductor copper wires
of American Wire Gauge 26 and a “U” shaped custom modified connector. Two pieces
of copper wire were twisted and soldered to the “U” shaped custom modified connec-
tor. The connector’s bare tips were separated by 5 mm and were approximately 5 mm
long. The dimensions of this probe were defined by the design of the implantable neu-
rostimulator system. The probe was designed to make contact with a set of screws that
secure leads inside the pulse generator can. Figure 1 demonstrates such set up. The
proximal end of the probe was connected to 1 Mega Ohm input impedance oscillo-
scope. The probe was oriented in a straight line parallel to the B field generated by the
RFID antenna and perpendicular to the neurostimulator leads.
RFID Emitter
A commercially available RFID system was used for exposing the implantable neurosti-
mulator system to magnetic fields. The system operated using International Organiza-
tion for Standardization 11785 Standard. The carrier frequency was 134.2 kHz, which
is considered low frequency, or LF RFID. Typically, systems with low carrier frequency
are used in access control of animals and people [12]. The maximum magnetic field
strength was measured to be 269 A/m at 2.5 cm away from the RFID antenna. The
pulse repetition rate of this system is 10.7 Hz. The RFID reader antenna dimensions
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was near the corners.
Implantable Neurostimulator System
A commercially available implantable neurostimulator system was analyzed for cou-
pling of electromagnetic fields. This system was previously approved by the FDA for
intended use of pain relief. The system consisted of an implantable pulse generator
and two implantable leads with platinum/iridium electrodes. Each lead was measured
to be 75 cm long with 8 electrode contacts. The system operated as an open loop sys-
tem and did not require a physiological signal for activation. The unique design of the
pulse generator, that enabled us to record from the electrodes, allowed us to perform
the tests without modifying the pulse generator or leads.
Patient Simulating Tank
We used a commercially available phantom ELI4, SPEAG. The phantom was made
from vinylester, glass fiber reinforced material which is capable of holding up to 30
liters of fluid. The inside of the phantom has oval shape of 40 cm × 60 cm with the 2
mm bottom plate. The phantom was filled with saline solution of electrical conductiv-
ity that represents electrical properties of the body [13].
SENN Model
The Spatially Extended Nonlinear Node (SENN) model was developed by J. Patrick
Reilly and Alan M. Diamant and recently published in Electrostimulation; Theory,
Applications, and Computational Model for modeling various nerve and muscle fibers
[14]. The SENN model is based on a program developed by Donald McNeal in 1976.
Reilly and Diamant have successfully employed this model in studying excitable tissue
Figure 1 Recording probe and pulse generator with leads attached.
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tial variations of electrical current in spinal cord fiber which includes variations in sti-
mulus wave shape, duration, repetition pattern, magnitude, means of delivery at
location of electrodes on the body, electrode size and biological and physiological fac-
tors. This model was previously used in analyzing medical applications of electro-sti-
mulation, electric shock, exposure limits to patients in medical applications,
electromagnetic safety standards and human reactions to electric weapons [14]. We
implemented this model in analyzing coupling of electromagnetic fields when in close
proximity to RFID emitters. The SENN model source code, supporting files, sample
executable for PC and Mac platforms and a startup guide are available as free down-
loads at http://www.artechhouse.com/static/reslib/reilly/reilly.html.
Procedure
A non-conductive, non-metallic plastic grid was used as a support grid for the neuro-
stimulator device and the lead system. The height of the grid was 7.7 mm. The plastic
grid with the neurostimulator system attached was placed inside the patient simulation
tank at the bottom. The tank was filled with 5280 μS/cm (0.528 S/m) conductivity sal-
ine to the top surface of the neurostimulator pulse generator. The conductivity value
was selected to match reported 561 Ohm resistance [15] between electrodes which
were 6 mm apart. The holes in the grid filled with the surrounding saline. Figures 2
and 3 demonstrate top and side views of the experimental set up.
Figure 2 Implantable Neurostimulator System configuration. Top View. Each neurostimulator lead is 75
cm long, forming circular loops along RFID antenna. Assume the neuron submerged and is oriented
perpendicular to the electrodes.
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antenna and the extra length was looped around the outline of the corners of the
antenna (Figure 2). The magnetic field around the corners of the antenna was pre-
viously recorded to generate the highest magnetic field strengths. This layout repre-
sents the worst case scenario for coupling electromagnetic fields into implantable
leads. The worst case scenario layout was also verified experimentally.
The neurostimulator system was programmed to measure the output impedance
between most distal electrodes of each lead. At the separation distance between edges
of electrodes of 6 mm and saline conductivity of 0.5280 S/m, the measured impedance
was 561 Ohms. This impedance value was within reported values for spinal cord sti-
mulators with dual lead configuration of 562 ± 389 Ohms [15].
Neurostimulator parameters were chosen from a recent study that reported electric
parameters optimized for spinal cord stimulation with conventional non-rechargeable
neurostimulator systems, with a sample size of 73 systems. The average reported para-
meters for best therapy were; amplitude of 5.3 mA, pulse width of 300 μsec and pulse
repetition of 100 Hz (10 msec) [15]. Since our implantable neurostimulator system was
a voltage controlled system, we calculated 5.3 mA (through 561 Ohms impedance) to
be 3 V. We programmed the neurostimulator system to output a waveform of 3 V
amplitude, 300 μsec pulse width and 100 Hz repetition rate.
Next, we connected our recording probe to the pulse generator. Using the oscillo-
scope, we verified programmed parameters and recorded the waveform. The same pro-
cedure was then performed three times to show repeatability.
We placed the RFID antenna underneath the saline-filled neurostimulator tank. The
antenna was oriented parallel to the loop formed by the neurostimulator system’s leads
and perpendicular to the recording probe. Figure 3 demonstrates the side view of the
layout. While the neurostimulator system was on, we turned on the RFID emitter. On
the oscilloscope, we measured and recorded the output waveform which contained the
waveform generated by the neurostimulator system and also the induced voltage
coupled into the implantable neurostimulator leads. The same procedure was then per-
formed three times to show repeatability.
The recorded data was then corrected for direct current (DC) coupling, possibly
causing an offset that was not balanced out. This particular type of offset is considered
to be caused by the recording set of instruments. The offset was determined by
Figure 3 Implantable neurostimulator system configuration inside patient simulation tank with
RFID antenna shown underneath the tank. Side View. The neuron is submerged 1.5 mm and is
oriented perpendicular to the electrodes.
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values [14].
The SENN model was then used to analyze corrected data to compile threshold fac-
tors for excitation of spinal cord fiber. The SENN model required a set of temporal
and spatial parameters. We obtained spinal cord fiber standard parameters for recruit-
ment of dorsal column fibers in spinal cord stimulation from previously published
work by Struijk et. al. [16]. Table 1 demonstrates the parameters in further detail. For
spatial parameters, we considered the worst case scenario (the shortest distance
between electrode and the nerve fiber) along with optimum electrode geometry pub-
lished by Holsheimer and Wesselink [17]. Table 2 defines spatial parameters in further
details.
Results
We recorded two types of output waveforms from the implantable neurostimulator
system. The first type of waveform contained only voltage signals from the implantable
neurostimulator system. The second type of waveform contained voltage signals gener-
ated by the implantable neurostimulator and induced voltage caused by EMI from the
RFID emitter. Figures 4 and 5 show the recorded waveforms respectively.
Next, we generated a time-ordered digital array of (x, y) pairs for each recorded out-
put waveform. In the SENN model, we used the sampled temporal waveform option,
IWAVE 13, which is commonly used to compute thresholds of temporal waveforms
recorded from electrical devices. In our case, we used this model to compute threshold
factors for excitation of spinal cord fiber. In order to process an array of sampled date,
the SENN model traces the waveform by indexing through the array and reading (x, y)
pairs [14].
We recorded the output waveform from implantable neurostimulator three times;
the SENN model generated three threshold multipliers of identical values, which were
0.22198. The reciprocal of 0.22198 is 4.5; this means that the waveform is 4.5 times
larger in amplitude than needed to generate an action potential in spinal cord fiber.
The reciprocal of a SENN threshold multiplier is also knows as a “threshold factor” or
the ratio of applied stimulus to stimulus at threshold of excitation.
Additionally, we recorded three output waveforms from implantable neurostimulator
with induced voltage caused by the RFID emitter. The SENN model generated three
threshold multipliers, 0.2304, 0.2304 and 0.2264. The corresponding threshold factors
are 4.34, 4.34 and 4.42 respectively. This means that the recorded waveform is 4.34
and 4.42 times larger in amplitude than needed to generate an action potential. We
expected all reciprocals of threshold multipliers to be greater than unity in amplitude
Table 1 Spinal Cord Fiber Standard Parameters for Recruitment of Dorsal Column Fibers
in Spinal Cord Stimulation [16]
Parameters Values
diameter of main fiber 6 μm
nodal length 1.5 μm
intra axonal resistivity 0.7 Ohm m
medium resistivity 0.58 Ohm m
membrane conductivity 1280 Ohm
-1 m
-2
membrane capacitance per unit area 0.02 F m
-2
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fibers at a time.
Furthermore, one of the objectives of this study was to determine the severity of EMI
caused by an RFID emitter. From the obtained multiplier thresholds, the results show
that a stimulation pulse with EMI from an RFID emitter has an effect that is equivalent
to a smaller in amplitude stimulating waveform. We did further investigation and
determined that the threshold factor of 4.34 in SENN model is equivalent to 5.1 mA
and 300 μsec output waveform from a spinal cord neurostimulator. Referring back to
the study where we obtained best therapy parameters for stimulation [15], the study
additionally lists a perception threshold of 4.6 mA in amplitude and 300 μsec in pulse
width and a discomfort threshold of 6.0 mA in amplitude and 300 μsec in pulse width.
Overall, the output waveform with amplitude of 5.1 mA is higher than the perception
threshold and lower than discomfort threshold.
Discussion
Overall, we recorded waveforms with and without induced voltage from RFID emitter.
The waveforms with induced voltage from RFID emitter received smaller threshold
factors than recorded waveforms without the induced voltage. This could be due to
the dominant set of waveforms generated by the neurostimulator system itself. We
referred to published in literature on strength-duration relationships derived from the
m y e l i n a t e dn e r v em o d e l s .T h ee l e c t r i cc u r r e n tt h r e s h o l d sf o rs i n g l e - c y c l eb i p h a s i cs t i -
muli with an initial cathodic phase and a point electrode that is 2 mm distant from 20
μm fiber are as follows. The current threshold for 300 μsec pulse width biphasic pulse
is approximately 0.6 mA, while the current threshold of 7.46 μsec (low frequency RFID
Table 2 Spatial Parameters in Spinal Cord Stimulation
Symbol Parameters Values (cm)
Xc x-coordinate of cathodic electrode 0.0
Yc y-coordinate of cathodic electrode 0.15
17
Xa x-coordinate of anodic electrode 0.6
Ya y-coordinate of anodic electrode 0.15
17
WireL wire electrode length 0.85
FS spatial field source wire electrodes
S electrode environment electrodes on surface
Figure 4 Recorded implantable neurostimulator output waveform.
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RFID pulse of 134 kHz in frequency is signification higher in frequency than pulses
generated by spinal cord neurostimulator system and therefore must be much higher
in amplitude in order to generate an action potential.
In our case, the signal generated by the neurostimulator was set at 5.3 mA peak,
which is larger than the reported 0.6 mA peak. The RFID interference was recorded at
approximately 18 mA, which is below the needed amplitude of 40 mA to generate an
action potential. When combined, in this case, the RFID interference caused a subtrac-
tive effect; the dominant waveform is minimized and therefore causes a slight reduc-
tion in threshold factors. This could be due to the way the neurostimulator system is
designed to generate waveforms. In Figures 5, the period between 400 μsec and 2
msec, the interference recorded is at the minimum. This could indicate that the elec-
trodes are connected to a high resistance inside the pulse generator. During switching
times, between 0-20 μsec and 300-400 μsec of Figure 5, the interference is recorded at
its maximum; this indicates that the electrodes are connected to a low impedance load
inside the pulse generator. Between the times of 20 μsec and 300 μsec or when the
pulse generator is outputting the monophasic pulse, it is not very clear how electrodes
are connected internally without knowing the circuitry used for generating waveforms.
If the neurostimulator system was designed differently, for example having a low
impedance connection between electrodes during the pulse output off period, this
would cause a significantly greater voltage across electrodes in saline, therefore causing
a significant addition to the output waveform that could potentially have an additive
effect on the stimulation threshold factor, possibly bringing stimulation parameters to
discomfort level.
Limitations
The study was conducted on a phantom filled with saline solution representing the
average conductivity of a spinal cord. The spinal cord is a complex structure consisting
of various layers of nerve fibers, gray matter, white matter, cerebrospinal fluid and epi-
dural fat; the electrical conductivities of which could vary in three orders of magnitude.
Changes in electrical conductivities could results in changes of electrical current sup-
plied by the neurostimulator system. The neurostimulator lead was configured for the
Figure 5 Recorded implantable neurostimulator output waveform when in close proximity to RFID
emitter.
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scenario represents the maximum coupling of electromagnetic fields into the neurosti-
mulator system leads and therefore the largest induced voltages. Such a configuration
does not represent the way such device would most likely be implanted. In addition,
the SENN model was used to analyze output waveforms of a single spinal cord fiber.
We applied this model to the best therapy stimulation parameters for one specific
nerve fiber and not to all fibers in the spinal cord.
Conclusion
From the results of our analysis, we concluded that electric currents induced by cou-
pling of magnetic fields from a LF RFID emitter to the leads of a neurostimulator do
not bring the best therapy stimulation parameters below perception threshold stimula-
tion parameters or above discomfort threshold stimulation parameters in one implan-
table neurostimulator system indicated for pain relief. Overall, we demonstrated a
method for analyzing effects of coupled magnetic field interference on implantable
neurostimulator systems and its electrodes which could be used by device manufac-
turers during the design and testing phases of the development process. This method
could also be applied to other implantable devices such as pacemakers, implantable
cardioverter defibrillators and other types of active implantable devices. Manufacturers
of active implantable devices need to be aware of the potential risk of EMI from RFID
emitters and design their medical devices appropriately. Additionally, RFID industry
should take into account the potential effects on active implantable medical devices
when designing, configuring and installing their systems. Moreover, patients and physi-
cians should all be aware of the possibility of adverse effects of implantable neurosti-
mulators from RFID emitters. In the future, our goal is to increase the number and
variety of tested implantable neurostimulators.
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